Results 111 to 120 of about 9,484 (203)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension

Clinical Ophthalmology, 2012
Fernanda Pacella, Paolo Turchetti, Valentina Santamaria, David Impallara, Gianpaolo Smaldone, Chiara Brillante, Aloisa Librando, Angela Damiano, Jose Pecori-Giraldi, Elena PacellaDepartment of Sense Organs, University of Rome "Sapienza ...
Pacella F, Turchetti P, Santamaria V, Impallara D, Smaldone G, Brillante C, Librando A, Damiano A, Pecori-Giraldi J, Pacella E   +8 more
doaj  

Preservative-free latanoprost induces meibomian gland dysfunction through inflammatory and oxidative stress pathways. [PDF]

BMC Pharmacol Toxicol
Huang C, Yang Y, Wu S, Liu Z, Chen L, Yan D, Wei M, Yan K, Wang R, Hu J, Li W, Liu Z.   +11 more
europepmc   +1 more source

Prostaglandin analog therapy challenges and innovation in glaucoma therapeutics. [PDF]

Indian J Ophthalmol
Nath M, Alam K, Halder N, Dada T, Thirumurthy V.   +4 more
europepmc   +1 more source

Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products [PDF]

, 2014

core   +1 more source

Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand? [PDF]

Adv Ther
Tsiampali C, Vagiakis I, Sardeli C, Konstas AG.   +3 more
europepmc   +1 more source

Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients [PDF]

, 2019
De Bacquer, Dirk, Kestelyn, Philippe, KESTELYN, PHILIPPE ADRIAAN, Stevens, AM   +3 more
core   +2 more sources

Latanoprost/timolol fixed-dose combination: two decades of efficacy and safety in glaucoma management. [PDF]

BMC Ophthalmol
Martinez-de-la-Casa J, Corsino P, Grzybowski A, Tatham A, Vignesh SO, Hassan T.   +5 more
europepmc   +1 more source

Drug induced hyperpigmentation: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Alharithy R, Alotaibi K, Bin Salamah R, Altamimi R, Alqntash N, Alsarhan R, Khosyfan L, Alrowais S.   +7 more
europepmc   +1 more source

Fifteen-Month Outcomes of Preservative-Free Latanoprost Cationic Emulsion in Open-Angle Glaucoma and Ocular Hypertension: Phase III Open-Label Extension of a Randomized Trial. [PDF]

Clin Ophthalmol
Stalmans I, Baudouin C, Larrosa JM, Schmickler S, Oddone F, Phase III study group.   +5 more
europepmc   +1 more source

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine^®) with Latanoprost Eye Drops (Xalatan^®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension. [PDF]

J Clin Med
Beck A, Rauschkolb-Olk KT, Welzel AM, Wolfrum P, Korb C, Schmidtmann I, Boehm EW, Lorenz K.   +7 more
europepmc   +1 more source